Clinical Trial

129Xe MRI Cardiopulmonary

Name: 129Xe MRI Cardiopulmonary — clinical trial record (NCT06038630)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.

Protocol Amendment History 6 amendments

This ClinicalTrials.gov record has been amended 6 times since 2023-09-08; most recent amendment 2026-02-02.

Status change: Not Yet Recruiting → Recruiting 2024-01-16

Trial Details

NCT Number	NCT06038630
Lead Sponsor	Bastiaan Driehuys Collaborators: National Institutes of Health (NIH)
Conditions	Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism, Anemia, Polycythemia, Dyspnea
Enrollment	125 participants
Start Date	2024-01-12
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-04